Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Atherosclerosis
|
August 1, 1994
Lipid testing for the year 2000 and beyond
D A Wiebe
Clinical Chemistry
|
July 1, 1993
Cholesterol--a model system to relate medical needs with analytical performance
D A Wiebe, J O Westgard
Clinical Chemistry
|
May 1, 1985
Six methods for isolating high-density lipoprotein compared, with use of the reference method for quantifying cholesterol in serum
D A Wiebe, S J Smith
Clinical Chemistry
|
November 1, 1991
Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing
J O Westgard, D A Wiebe
Clinical Chemistry
|
March 1, 1984
Influence of incomplete cholesteryl ester hydrolysis on enzymic measurements of cholesterol
D A Wiebe, J T Bernert
Therapeutic Drug Monitoring
|
May 1, 1991
Application of the Empore solid-phase extraction membrane to the isolation of drugs from blood. I. Amiodarone and desethylamiodarone
G L Lensmeyer, D A Wiebe, T Doran
Clinical Chemistry
|
May 1, 1991
Laboratory process specifications for assuring quality in the U.S. National Cholesterol Education Program
J O Westgard, P H Petersen, D A Wiebe
Therapeutic Drug Monitoring
|
October 1, 1992
Application of the Empore solid-phase extraction membrane to the isolation of drugs from blood: II. Mexiletine and flecainide
G L Lensmeyer, D A Wiebe, T C Doran
Clinical Chemistry
|
October 1, 1987
Identification and analysis of nine metabolites of cyclosporine in whole blood by liquid chromatography. 1: Purification of analytical standards and optimization of the assay
G L Lensmeyer, D A Wiebe, I H Carlson
Therapeutic Drug Monitoring
|
June 1, 1997
Optimized high-performance liquid chromatographic method for determination of lamotrigine in serum with concomitant determination of phenytoin, carbamazepine, and carbamazepine epoxide
G L Lensmeyer, B E Gidal, D A Wiebe
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Atherosclerosis
|
August 1, 1994
Lipid testing for the year 2000 and beyond
D A Wiebe
Clinical Chemistry
|
July 1, 1993
Cholesterol--a model system to relate medical needs with analytical performance
D A Wiebe, J O Westgard
Clinical Chemistry
|
May 1, 1985
Six methods for isolating high-density lipoprotein compared, with use of the reference method for quantifying cholesterol in serum
D A Wiebe, S J Smith
Clinical Chemistry
|
November 1, 1991
Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing
J O Westgard, D A Wiebe
Clinical Chemistry
|
March 1, 1984
Influence of incomplete cholesteryl ester hydrolysis on enzymic measurements of cholesterol
D A Wiebe, J T Bernert
Therapeutic Drug Monitoring
|
May 1, 1991
Application of the Empore solid-phase extraction membrane to the isolation of drugs from blood. I. Amiodarone and desethylamiodarone
G L Lensmeyer, D A Wiebe, T Doran
Clinical Chemistry
|
May 1, 1991
Laboratory process specifications for assuring quality in the U.S. National Cholesterol Education Program
J O Westgard, P H Petersen, D A Wiebe
Therapeutic Drug Monitoring
|
October 1, 1992
Application of the Empore solid-phase extraction membrane to the isolation of drugs from blood: II. Mexiletine and flecainide
G L Lensmeyer, D A Wiebe, T C Doran
Clinical Chemistry
|
October 1, 1987
Identification and analysis of nine metabolites of cyclosporine in whole blood by liquid chromatography. 1: Purification of analytical standards and optimization of the assay
G L Lensmeyer, D A Wiebe, I H Carlson
Therapeutic Drug Monitoring
|
June 1, 1997
Optimized high-performance liquid chromatographic method for determination of lamotrigine in serum with concomitant determination of phenytoin, carbamazepine, and carbamazepine epoxide
G L Lensmeyer, B E Gidal, D A Wiebe
Page
of 5